Clinical Trial Update: Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of dihydroartemisinin/piperaquine (Artekin) for uncomplicated malaria in Peru has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artekin (dihydroartemisinin/piperaquine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Malaria | Phase 3 | Status: COMPLETED